Richard Koenig

Executive Director, Project Management, Psychiatry and Neuroscience Rare Diseases

Richard Koenig is Executive Director, Project Management, Psychiatry and Neuroscience Rare Diseases for Worldwide Clinical Trials. He has more than two decades of clinical research experience, specializing in CNS disorders and extending to a broad range of therapeutic areas. His portfolio spans all phases of study and ranges from small regional projects to global-scale programs. Whether working with a small biotech or a large pharmaceutical company, he applies localized attention to sponsor needs.


Richard has 21 years of clinical research experience at both large global and small regionally focused CROs. His therapeutic area experience covers a variety of indications in psychiatry and neurology including: schizophrenia, major depressive disorder, attention deficit/hyperactivity disorder, Parkinson’s disease, analgesia, muscular dystrophy, and insomnia. Richard has managed project teams supporting clinical trials in Phases I through IV, with sponsors in North America, Europe, and Japan. This experience includes both small biotech sponsors and global programs for large pharmaceutical sponsors. In addition to experience with CNS-focused studies, Richard also has experience with therapeutic indications in women’s health, general medicine , dermatology, and ophthalmology.

Richard received a BA in political science and an MPA, public administration and health care from Long Island University.



Tamara Ast, PhD

Executive Vice President, Global Therapeutic Lead, Neuroscience

Read my bio

Aman Khera

Global Head of Regulatory Strategy

Read my bio

Lisa Leuzzi

Vice President, Project Management, Psychiatry and Neurology

Read my bio